MA-DESKTOP-METAL
18.6.2024 14:31:33 CEST | Business Wire | Press release
Desktop Metal (NYSE: DM), a global leader in Additive Manufacturing 2.0 technologies for mass production, today announced that platinum is now a customer-qualified material on the Production System™ P-1 with a specialty powder developed by Legor.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240618795152/en/
Platinum jewelry designs 3D printed by Legor on a Desktop Metal Production System P-1 are slated to be part of a multi-material, multi-customer jewelry display featured by Desktop Metal at Rapid + TCT, North America’s largest additive manufacturing and industrial 3D printing event, to be held June 25-27 in Los Angeles. The Legor parts to be shown include including a classic wedding band, a gemstone ring, and an intricate leaf earring. (Photo: Business Wire)
Legor is a full-service jewelry manufacturing solutions provider, and the company’s Powmet line of certified ultra-pure metal powders is produced for use with both laser and binder jet 3D printing systems.
“The qualification of Legor’s Powmet platinum on the Production System P-1 is another major milestone for binder jet 3D printing for the jewelry, watchmaking, and luxury goods industry,” said Ric Fulop, Founder and CEO of Desktop Metal. “Platinum is known to be a challenging-to-process material in the jewelry industry because of its high hardness and melting point. Our binder jet 3D printing process simplifies platinum production and enables all-new, once-impossible designs.”
”Legor is currently experiencing significant market interest in 3D printing technology, specifically in binder jet technology,” added Fabio Di Falco, Marketing and Customer Support Manager at Legor. “This has led us to address a variety of requests, ranging from prototyping to small batch production, as well as larger production runs. Thanks to binder jet 3D printing technology, designers can finally imagine and create objects that are currently unproducible with other technologies, thus expanding the boundaries of creativity to shape the future. At Legor, we are committed to becoming catalysts for innovation and promoting technology we are convinced represents a crucial turning point for our industry.”
Platinum jewelry designs 3D printed by Legor — including a classic wedding band, a gemstone ring, and an intricate leaf earring — are slated to be part of a multi-material, multi-customer jewelry display featured by Desktop Metal at Rapid + TCT, North America’s largest additive manufacturing and industrial 3D printing event, to be held June 25-27 in Los Angeles.
Binder Jet 3D Printing for Jewelry and Watchmaking
In 2023, Legor invested in a Desktop Metal Production System P-1, a high-speed, 1-liter binder jet 3D printing system featuring Single Pass Jetting (SPJ) technology. The experienced jewelry manufacturer notes that binder jet 3D printing technology offers several benefits over traditional manufacturing methods and other forms of 3D printing for jewelry production including:
- Rapid production of jewelry samples without molds or printing supports
- All-new design freedom for fast, affordable production of hollow, interlinked, intricate, and mass customized designs
- Elimination of processing steps associated with jewelry designs, such as welding
- Simplified production of materials that are difficult to work with, such as platinum, which often requires special tools
- Low waste production that is eco-friendly and uses only the necessary amount of metal needed to create the design
Legor’s Di Falco noted that sustainability is an important feature of binder jet 3D printing technology for the jewelry industry and Legor specifically.
“Binder jet 3D printing technology represents a significant step toward more sustainable production,” he noted, “enabling energy efficiency, and reducing the amount of material used. Indeed, binder jetting uses exactly the amount of material necessary to create an object, drastically reducing waste. The metal powder not used in the process can be reused, reducing the need for new raw materials and the risks associated with metal extraction. At Legor, we advocate for 3D printing as a responsible production approach that also considers the planet and people.”
A video by Legor showing the benefits of binder jetting platinum jewelry can be viewed at https://legor.com/en/prodotto/platinum-3d-printing/.
For more information about binder jetting jewelry with DM technologies, visit TeamDM.com/jewelry.
About Desktop Metal
Desktop Metal (NYSE:DM) is driving Additive Manufacturing 2.0, a new era of on-demand, digital mass production of industrial, medical, and consumer products. Our innovative 3D printers, materials, and software deliver the speed, cost, and part quality required for this transformation. We’re the original inventors and world leaders of the 3D printing methods we believe will empower this shift, binder jetting and digital light processing. Today, our systems print metal, polymer, sand and other ceramics, as well as foam and recycled wood. Manufacturers use our technology worldwide to save time and money, reduce waste, increase flexibility, and produce designs that solve the world’s toughest problems and enable once-impossible innovations. Learn more about Desktop Metal and our #TeamDM brands at www.desktopmetal.com.
Forward-looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical facts contained in these communications, including statements regarding Desktop Metal’s future results of operations and financial position, financial targets, business strategy, and plans and objectives for future operations, are forward-looking statements. Forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to: risks associated with the integration of the business and operations of acquired businesses; Desktop Metals’ ability to realize the benefits from cost saving measures; supply and logistics disruptions, including shortages and delays. For more information about risks and uncertainties that may impact Desktop Metal’s business, financial condition, results of operations and prospects generally, please refer to Desktop Metal’s reports filed with the SEC, including without limitation the “Risk Factors” and/or other information included in the Form 10-Q filed with the SEC on August 3, 2023, and such other reports as Desktop Metal has filed or may file with the SEC from time to time. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Desktop Metal, Inc. assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240618795152/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
